This page shows you the latest news items in this category. This is page number 13.
Total 484 results found since Jan 2013.
Torrent Pharma Inc - 584701 - 10/28/2019
CGMP/Finished Pharmaceuticals/Adulterated
Source: FDA Center for Drug Evaluation and Research - What's New - November 19, 2019 Category: Drugs & Pharmacology Authors: Office of Pharmaceutical Quality Operations, Division I Source Type: news
Gender commonalities and differences in risk and protective factors of suicidal thoughts and behaviors: A cross-sectional study of Spanish university students - Miranda-Mendiz ábal A, Castellví P, Alayo I, Vilagut G, Blasco MJ, Torrent A, Ballester L, Almenara J, Lagares C, Roca M, Sese A, Piqueras JA, Soto-Sanz V, Rodríguez-Marín J, Echeburúa E, Gabilondo A, Cebrià AI, Bruffaerts R, Auerbach RP, Mortier P, Kessler RC, Alonso J.
AIM: To assess gender differences in the association between risk/protective factors and suicidal thoughts and behaviors (STB); and whether there is any gender-interaction with those factors and STB; among Spanish university students. METHODS: Data...
Source: SafetyLit - October 19, 2019 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
FDA calls out Torrent as key contributor to major recall
The FDA has issued a warning letter to Torrent Pharmaceuticals and said the company is at the center of its investigation into a global recall of several blood pressure medications.
Source: PharmaManufacturing.com - October 17, 2019 Category: Pharmaceuticals Source Type: news
FDA Slams Torrent Over Losartan Manufacturing Lapses FDA Slams Torrent Over Losartan Manufacturing Lapses
The company was cited for quality-control violations and other issues regarding its manufacture of losartan potassium tablets at one of its facilities in India.Medscape Medical News
Source: Medscape Cardiology Headlines - October 16, 2019 Category: Cardiology Tags: Cardiology News Source Type: news
Torrent Pharmaceuticals Limited - 585255 - 10/08/2019
CGMP/Finished Pharmaceuticals/Adulterated
Source: FDA Center for Drug Evaluation and Research - What's New - October 15, 2019 Category: Drugs & Pharmacology Authors: Center for Drug Evaluation and Research Source Type: news
Torrent Pharma recalls 74k bottles of hypertension drug from US
As per the report, Torrent Pharma Inc is recalling 17,088 bottles of Losartan Potassium /Hydrochlorothiazide tablets, USP 50mg/12.5mg from the same markets.
Source: The Economic Times Healthcare and Biotech News - October 12, 2019 Category: Pharmaceuticals Source Type: news
Medical News Today: More batches of common hypertension drug taken off the market
Torrent Pharmaceuticals Ltd. is withdrawing more batches of Losartan potassium tablets, USP and Losartan potassium/hydrochlorothiazide tablets, USP.
Source: Health News from Medical News Today - September 27, 2019 Category: Consumer Health News Tags: Hypertension Source Type: news
More Blood Pressure Drugs Recalled
TUESDAY, Sept. 24, 2019 -- The recall of the commonly prescribed blood pressure drug losartan has been expanded once again to include an additional five lots.
The drug, made by Torrent Pharmaceuticals, has been recalled because some lots are...
Source: Drugs.com - Pharma News - September 24, 2019 Category: Pharmaceuticals Source Type: news
FDA Expands Recall Of Blood Pressure Drugs Again
(CNN) — Torrent Pharmaceuticals Ltd. has expanded its voluntary recall of two blood pressure medications after trace amounts of a potentially cancer-causing impurity were found during testing.
The recall affects Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets.
Tests of some of those medications revealed amounts of N-methylnitrosobutyric acid (NMBA) that were above the US Food and Drug Administration’s daily acceptable levels.
This recall is related to the valsartan recall that has been expanded multiple times since July, when separate lots of blood pressure medications from dif...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - September 24, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Syndicated CBSN Boston CNN Recall Valsartan Source Type: news
Torrent Recalls More Tainted Losartan Torrent Recalls More Tainted Losartan
It ' s the fifth recall by Torrent of losartan-containing medicines due to detection of unacceptable levels of a potential carcinogen.News Alerts
Source: Medscape Cardiology Headlines - September 23, 2019 Category: Cardiology Tags: Cardiology News Alert Source Type: news
More Blood Pressure Medication Recalls Due To Cancer Concerns
According to the U.S. Food and Drug Administration (FDA), Torrent Pharmaceuticals Limited has expanded its recall of blood pressure medications.
Source: Forbes.com Healthcare News - September 21, 2019 Category: Pharmaceuticals Authors: Bruce Y. Lee, Contributor Source Type: news
Exclusive: Trust will need ‘mutual aid’ in no-deal Brexit scenario
South East Coast Ambulance Service Foundation Trust has warned it will need “mutual aid” from other NHS providers and is highly likely to move to the highest emergency response category, REAP level 4, if there is a no-deal Brexit in October, HSJ has learned.
Source: HSJ - September 20, 2019 Category: UK Health Source Type: news
Updated: Torrent Pharmaceuticals Limited Expands Voluntary Nationwide Recall of Losartan Potassium Tablets, USP and Losartan Potassium / Hydrochlorothiazide Tablets, USP
Torrent Pharmaceuticals Limited is expanding its recall for Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets, USP, to the consumer level due to the detection of trace amounts of an unexpected impurity.
Source: FDA Center for Drug Evaluation and Research - What's New - September 20, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news
One of Nashville's larger nonprofits names new CEO
Tennessee ’s longest operating hospice provider has a new leader.
Kimberly Goessele has been named president and CEO of Alive Hospice, effective Sept. 23, according to a news release. She succeeds Anna-Gene O’Neal, who left the non-profit in June to run Brentwood-based Brookdale Senior Living’s hospi ce division.
Goessele was most recently chief operating officer at Franklin-based 180 Health Partners, where she led business development and strategy for the organization, which provides aid…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 19, 2019 Category: Pharmaceuticals Authors: Joel Stinnett Source Type: news
Persistent impact of housing loss on cognitive decline after the 2011 Great East Japan earthquake and tsunami: evidence from a 6-year longitudinal study - Hikichi H, Aida J, Kondo K, Kawachi I.
INTRODUCTION: We previously established that housing loss and residential dislocation in the 2011 Japan earthquake and tsunami was a risk factor for cognitive decline among older survivors. The present study extends the follow-up of survivors out to 6 yea...
Source: SafetyLit - August 8, 2019 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news
